Zobrazeno 1 - 10 of 66 pro vyhledávání: '"Wayne Macfadden"'
2
Akademický článek
Implications of Oxybate Dosing Regimen for Sleep, Sleep Architecture, and Disrupted Nighttime Sleep in Patients with Narcolepsy: A Commentary
Autor: Russell Rosenberg, Rogelio Braceras, Wayne Macfadden, Shawn Candler, Jed Black, Chad Ruoff
Publikováno v: Neurology and Therapy, Vol 12, Iss 6, Pp 1805-1820 (2023)
Abstract Narcolepsy is associated with disrupted nighttime sleep (DNS). Sodium oxybate (SXB; Xyrem®), administered twice nightly, is indicated for the treatment of cataplexy and excessive daytime sleepiness in patients 7 years or older with narcolep
Externí odkaz: https://doaj.org/article/afed787cda9b4829b7d82d79ca02a5a9
Zobrazit plný text záznamu
3
Akademický článek
Functional versus functional and anatomical criteria-guided ranibizumab treatment in patients with neovascular age-related macular degeneration – results from the randomized, phase IIIb OCTAVE study
Autor: Giovanni Staurenghi, Justus G. Garweg, Bianca S. Gerendas, Wayne Macfadden, Boris Gekkiev, Philippe Margaron, Cornelia Dunger-Baldauf, Petr Kolar
Publikováno v: BMC Ophthalmology, Vol 20, Iss 1, Pp 1-11 (2020)
Abstract Background To evaluate the efficacy and safety of two individualized ranibizumab retreatment schemes in neovascular age-related macular degeneration. Methods Patients (N = 671) were randomized (1:1) to receive three initial monthly ranibizum
Externí odkaz: https://doaj.org/article/8af5d6c0b3f64bc9b8dd8411440f3e58
Zobrazit plný text záznamu
4
Akademický článek
Effectiveness and safety of ranibizumab 0.5 mg in treatment-naïve patients with diabetic macular edema: Results from the real-world global LUMINOUS study.
Autor: Paul Mitchell, Tom G Sheidow, Michel E Farah, Sajjad Mahmood, Angelo M Minnella, Nicole Eter, Bora Eldem, Hassan Al-Dhibi, Wayne Macfadden, Soumil Parikh, Cornelia Dunger-Baldauf, Mohamed M Mahgoub, Ursula Schmidt-Erfurth, LUMINOUS study investigators
Publikováno v: PLoS ONE, Vol 15, Iss 6, p e0233595 (2020)
PURPOSE:To assess the one-year effectiveness and safety of ranibizumab 0.5 mg in treatment- naïve patients with diabetic macular edema (DME) enrolled in the real-world LUMINOUS study. PATIENTS AND METHODS:A 5-year, prospective, observational, open-l
Externí odkaz: https://doaj.org/article/4d9e6ea8da7c4824bcf8e5f198cfacdc
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje